Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The immune modulator Pomalyst led to remission in two thirds of people with AIDS-related Kaposi sarcoma.
I was one of those physicians providing care to gay men in New York City when AIDS first came to attention.
The immune modulator Pomalyst led to remission in two thirds of people with AIDS-related KS.
Long-term survivor John Reams shared his story of profound loss and immense gratitude.
Peer support is more important than ever.
POZ asked readers: How did HIV change your life? A long-term survivor shares his story of profound loss and immense gratitude.
Study suggests immune-based cancer therapies might be particularly beneficial for HIV-positive people.
Researchers analyzed autopsies among people with HIV who died in New York City since 1984.
The Office of HIV and AIDS Malignancy at the National Cancer Institute coordinates cancer and HIV research.
Treatment with checkpoint inhibitors appears safe and effective for HIV-positive people.
Researchers looked both at the first and second time people with HIV have been diagnosed with cancer.
Six out of nine patients experienced cancer remission with Opdivo or Keytruda.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
Its decline after the advent of antiretroviral therapy did not extend to Black men in the South.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.